Fructose Malabsorption in Northern Norway (FINN)

U

University Hospital of North Norway

Status and phase

Completed
Phase 3
Phase 2

Conditions

Irritable Bowel Syndrome
Fructose Malabsorption

Treatments

Behavioral: diet restriction

Study type

Interventional

Funder types

Other

Identifiers

NCT00555191
N-136/2006(REK)
15567/NSD (Other Identifier)
Ref 1204 Biobankregisteret (Registry Identifier)
2006/136(REK-N) (Registry Identifier)

Details and patient eligibility

About

Different published studies has shown a possible co-variation between leakage of fructose to the great bowel and exacerbation of irritable bowel syndrome (IBS) symptoms. The aim of the FINN trial is to study the role of fructose malabsorption in patients with IBS in order to evaluate different diagnostic criteria for fructose malabsorption and at the same time study the effect of diet treatment in this cohort of patients and estimate the prevalence of fructose malabsorption.

Enrollment

182 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • IBS patients satisfying ROME 2 diagnostic criteria

Exclusion criteria

  • Seriously ill
  • Organic abdominal disease
  • Other functional bowel disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

182 participants in 2 patient groups

1
Active Comparator group
Description:
PATIENTS IN THIS ARM IS INSTRUCTED IN FRUCTOSE REDUCED DIET FOR A PERIOD OF 3 MONTHS
Treatment:
Behavioral: diet restriction
2
No Intervention group
Description:
these patients use their usual diet

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems